Triglyceride–Glucose Index as a Predictor of Major Adverse Cardiovascular Events in Post-PCI Patients Diagnosed with In-Stent Restenosis

References

• Giustino G, Colombo A, Camaj A, et al.. Coronary in-stent restenosis: JACC State-of-The-Art Review. J Am Coll Cardiol. 2022;80(4):348–372. doi:10.1016/j.jacc.2022.05.017
   PubMed Web of Science ®Google Scholar
• Collet JP, Thiele H, Barbato E, et al. ESC Scientific Document Group. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367.
   PubMed Web of Science ®Google Scholar
• Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas gruentzig lecture ESC 2014. Eur Heart J. 2015;36(47):3320–3331. doi:10.1093/eurheartj/ehv511
   PubMed Web of Science ®Google Scholar
• Madhavan MV, Kirtane AJ, Redfors B, et al. Stent-related adverse events >1 year after percutaneous coronary intervention. J Am Coll Cardiol. 2020;75(6):590–604. doi:10.1016/j.jacc.2019.11.058
   PubMed Web of Science ®Google Scholar
• Goto K, Zhao Z, Matsumura M, et al. Mechanisms and patterns of intravascular ultrasound in-stent restenosis among bare metal stents and first- and second-generation drug-eluting stents. Am J Cardiol. 2015;116(9):1351–1357. doi:10.1016/j.amjcard.2015.07.058
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim KH, Oh IY, et al. Comparison of plain balloon and cutting balloon angioplasty for the treatment of restenosis with drug-eluting stents vs bare metal stents. Circ J. 2010;74(9):1837–1845. doi:10.1253/circj.CJ-09-1041
   PubMed Web of Science ®Google Scholar
• Iqbal J, Serruys PW, Silber S, et al. Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial. Circ Cardiovasc Interv. 2015;8(6):e002230. doi:10.1161/CIRCINTERVENTIONS.114.002230
   PubMed Web of Science ®Google Scholar
• Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347(17):1342–1349. doi:10.1056/NEJMcp021106
   PubMed Web of Science ®Google Scholar
• Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019;13(2):1449–1455. doi:10.1016/j.dsx.2019.02.023
   PubMed Web of Science ®Google Scholar
• Zhu Y, Liu K, Chen M, et al.. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovasc Diabetol. 2021;20(1):137. doi:10.1186/s12933-021-01332-4
   PubMed Web of Science ®Google Scholar
• Guo X, Shen R, Yan S, Su Y, Ma L. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):43. doi:10.1186/s12933-023-01779-7
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/ EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi:10.1093/eurheartj/ehy394
   PubMed Web of Science ®Google Scholar
• Nusca A, Viscusi MM, Piccirillo F, et al. In stent neo-atherosclerosis: pathophysiology, clinical implications, prevention, and therapeutic approaches. Life. 2022;12(3):393. doi:10.3390/life12030393
   PubMedGoogle Scholar
• Brito ADM, Hermsdorff HHM, Filgueiras MS, et al.. Predictive capacity of triglyceride glucose (TyG) index for insulin resistance and cardiometabolic risk in children and adolescents: a systematic review. Crit Rev Food Sci Nutr. 2021;61(16):2783–2792. doi:10.1080/10408398.2020.1788501
   PubMed Web of Science ®Google Scholar
• Laakso M, Kuusisto J. Insulin resistance and hyperglycemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302. doi:10.1038/nrendo.2014.29
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang C, Che H, et al. Correction to: association between the triglyceride-glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China. Cardiovasc Diabetol.2023;22(1):171
   PubMed Web of Science ®Google Scholar
• Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the bruneck study. Diabetes Care. 2007;30:318–324. doi:10.2337/dc06-0919
   PubMed Web of Science ®Google Scholar
• Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56(23):1897–1907. doi:10.1016/j.jacc.2010.07.028
   PubMed Web of Science ®Google Scholar
• Kitta Y, Nakamura T, Kodama Y, et al. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol. 2005;46(4):648–655.
   PubMed Web of Science ®Google Scholar
• Kurmuş Ferik Ö, Yetiş Sayın B, Akbuğa K, Zorlu Ç. Association between insulin resistance estimated by Triglyceride Glucose Index and In-stent restenosis in non-diabetic patients. EJCM. 2022;10(1):12–17. doi:10.32596/ejcm.galenos.2022.2021-11-060
   Google Scholar
• Kaplangoray M, Toprak K, Başanalan F, et al.. Investigation of the relationship between triglycerides-glucose index and coronary slow flow: a retrospective case-control study. Arq Bras Cardiol. 2023;120(6):e20220679. doi:10.36660/abc.20220679
   PubMed Web of Science ®Google Scholar
• Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36(32):2147–2159. doi:10.1093/eurheartj/ehv205
   PubMed Web of Science ®Google Scholar
• Rathore S, Kinoshita Y, Terashima M, et al. A comparison of clinical presentations, angio-graphic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents. Euro Intervent. 2010;5(7):841–846. doi:10.4244/eijv5i7a141
   Google Scholar
• Nakano H, Kataoka Y, Otsuka F, et al. Refractory In-stent restenosis attributable to eruptive calcified nodule. J Am Coll Cardiol Case Rep. 2020;2(12):1872–1878.
   Google Scholar
• Assali AR, Moustapha A, Sdringola S, et al. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol. 2006;98(6):729–733. doi:10.1016/j.amjcard.2006.04.007
   PubMed Web of Science ®Google Scholar
• Yang J, Tang YD, Zheng Y, et al.. The impact of the Triglyceride-Glucose Index on poor prognosis in nondiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol. 2021;12:710240. doi:10.3389/fendo.2021.710240
   PubMed Web of Science ®Google Scholar
• Chen L, Ding XH, Fan KJ, et al. Association between Triglyceride-Glucose Index and 2-year adverse cardiovascular and cerebrovascular events in patients with type 2 diabetes mellitus who underwent off-pump coronary artery bypass grafting. Diabetes Metab Syndr Obes. 2022;15:439–450. doi:10.2147/DMSO.S343374
   PubMed Web of Science ®Google Scholar
• Qin Z, Xu S, Yuan R, et al.. Combination of tyg index and grace risk score as long-term prognostic marker in patients with acs complicated with t2dm undergoing PCI. Diabetes Metab Syndr Obes. 2022;15:3015–3025. doi:10.2147/DMSO.S376178
   PubMed Web of Science ®Google Scholar
• Wu Z, Xie L, Guo D, et al.. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study. Cardiovasc Diabetol. 2023;22(1):230. doi:10.1186/s12933-023-01969-3
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhang TY, Cheng YJ, et al. Triglyceride-Glucose Index as a surrogate marker of insulin resistance for predicting cardiovascular outcomes in nondiabetic patients with non-st-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021;28(11):1175–1194. doi:10.5551/jat.59840
   PubMed Web of Science ®Google Scholar
• Al Jumaily T, Rose’Meyer RB, Sweeny A, Jayasinghe R. Cardiac damage associated with stress hyperglycaemia and acute coronary syndrome changes according to level of presenting blood glucose. Int J Cardiol. 2015;196:16–21. doi:10.1016/j.ijcard.2015.05.143
   PubMed Web of Science ®Google Scholar
• Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8. doi:10.1186/s12933-019-0982-2
   PubMed Web of Science ®Google Scholar